Patents by Inventor Gregg Peterson

Gregg Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS
    Publication number: 20230405018
    Abstract: Provided herein are subcutaneous formulations of flumazenil that are useful for treating a variety of disease and disorders. The subcutaneous flumazenil formulations provided herein reduce injection site irritation and pain and allow for home administration to enhance patient compliance.
    Type: Application
    Filed: November 17, 2021
    Publication date: December 21, 2023
    Inventors: Jeffrey BECKER, Gregg PETERSON
  • SYSTEMS AND DEVICES FOR CONTROLLED DRUG DELIVERY
    Publication number: 20230330328
    Abstract: Provided herein are systems, devices, kits, and methods for administering liquid drug formulation by titratable subcutaneous or intramuscular administration.
    Type: Application
    Filed: June 11, 2021
    Publication date: October 19, 2023
    Inventors: Sheldon Blain MOBERG, Moshe BARKAN, Jeffrey BECKER, Gregg PETERSON
  • COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS
    Publication number: 20230124101
    Abstract: Provided herein are pharmaceutical formulations and pharmaceutical compound salts which utilize complexing agents as counterions. Such formulations and salts are useful for treating a variety of disease and disorders.
    Type: Application
    Filed: November 4, 2022
    Publication date: April 20, 2023
    Inventors: Jeffrey BECKER, Gregg Peterson, Jason Wallach
  • Complexing agent salt formulations of pharmaceutical compounds
    Patent number: 11534454
    Abstract: Provided herein are pharmaceutical formulations and pharmaceutical compound salts which utilize complexing agents as counterions. Such formulations and salts are useful for treating a variety of disease and disorders.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: December 27, 2022
    Assignee: Bexson Biomedical, Inc.
    Inventors: Jeffrey Becker, Gregg Peterson, Jason Wallach
  • COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS
    Publication number: 20220152088
    Abstract: Provided herein are pharmaceutical formulations and pharmaceutical compound salts which utilize complexing agents as counterions. Such formulations and salts are useful for treating a variety of disease and disorders.
    Type: Application
    Filed: December 9, 2021
    Publication date: May 19, 2022
    Inventors: Jeffrey BECKER, Gregg Peterson, Jason Wallach
  • KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
    Publication number: 20210186896
    Abstract: Provided herein are subcutaneous formulations of ketamine that are useful for treating a variety of disease and disorders. The subcutaneous ketamine formulations provided herein reduce injection site irritation and pain.
    Type: Application
    Filed: February 26, 2021
    Publication date: June 24, 2021
    Inventors: Jeffrey BECKER, Gregg PETERSON, Jason WALLACH
  • Ketamine formulation for subcutaneous injection
    Patent number: 10973780
    Abstract: Provided herein are subcutaneous formulations of ketamine that are useful for treating a variety of disease and disorders. The subcutaneous ketamine formulations provided herein reduce injection site irritation and pain.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: April 13, 2021
    Assignee: Bexson Biomedical, Inc.
    Inventors: Jeffrey Becker, Gregg Peterson, Jason Wallach
  • SYSTEMS, DEVICES, FORMULATIONS AND METHODS FOR CONTROLLED DRUG DELIVERY
    Publication number: 20200384188
    Abstract: Provided herein are systems, devices, formulations, and methods for treating a subject for treating, preventing, or ameliorating at least one symptom of a disorder, disease, or condition according to a controlled dosage regimen to provide effective treatment while reducing the risk of side effects or abuse.
    Type: Application
    Filed: November 14, 2018
    Publication date: December 10, 2020
    Inventors: Jeffrey BECKER, Gregg PETERSON, Jason WALLACH
  • KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
    Publication number: 20200360308
    Abstract: Provided herein are subcutaneous formulations of ketamine that are useful for treating a variety of disease and disorders. The subcutaneous ketamine formulations provided herein reduce injection site irritation and pain.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Jeffrey Becker, Gregg Peterson, Jason Wallach